X

WHY BLOOM BURTON & CO?
SERVICES
TRANSACTIONS
TEAM
EVENTS
News & Insights
CAREERS
CONTACT

•

M

E

N

U

•

May 1, 2015

Brian Bloom speaks to BNN about the state of biotech in Canada

As with all our posts, please see our legal disclaimer.

RELATED NEWS

Three Finalists Announced for the 2025 Bloom Burton Award Conavi Medical Corp. Announces Closing of $20M Public Offering Registration is now open for the 2025 Bloom Burton & Co. Healthcare Investor Conference! Medexus Pharmaceuticals Announces Closing of $30 Million Overnight Marketed Public Offering of Common Shares Bloom Burton & Co. Announces the 2025 Bloom Burton Award The Globe and Mail | AstraZeneca to invest $820 million in Ontario life science sector, says it will create 700 jobs Satellos Announces Closing of US$40M Public Offering The Globe and Mail | Rare milestone for Canadian biotech as Zymeworks-developed drug gets FDA approval Titan Announces the Closing of Conavi’s Private Placement of Subscription Receipts and Provides Update on the Transaction Roberto Bellini Receives the 2024 Bloom Burton Award

2025 BLOOM BURTON & CO DESIGNED & DEVELOPED BY THE TEAM AT PIXELCARVE MEMBER CIRO MEMBER CIPF PRIVACY POLICY COMPLAINT BEST EXECUTION POLICY ACCESSIBILITY POLICY BUSINESS CONTINUITY PLAN LEGAL DISCLAIMER CONFLICTS OF INTEREST